Samsung Biologics: A Leader in Biopharma Water Security
Generated by AI AgentMarcus Lee
Wednesday, Feb 12, 2025 7:06 am ET1min read
RAIN--
Samsung Biologics, a global contract development and manufacturing organization (CDMO), has been recognized for its leadership in water security within the biopharmaceutical industry. The company's commitment to sustainability and responsible business practices has positioned it as a trailblazer in water management and conservation.

Samsung Biologics has implemented a comprehensive water management strategy that focuses on recycling and reuse, wastewater treatment, rainwater harvesting, and efficient water use in clean rooms. These initiatives have enabled the company to achieve a water recycling and reuse rate of 20% across its business sites and supply chain in 2023, with a target of increasing this rate to 36% by 2030.
The company's water security performance compares favorably to industry peers and best practices in the biopharmaceutical sector. In 2023, Samsung Biologics achieved a water recycling and reuse rate of 20%, which is higher than the industry average of 10-15% (Alliance for Water Stewardship, 2021). This commitment to water security is aligned with best practices in the biopharmaceutical sector and has been recognized through numerous awards and certifications, such as the EcoVadis Platinum Sustainability Rating and the Terra Carta Seal from the Sustainable Markets Initiative (Samsung Biologics, 2024).
Samsung Biologics' water security initiatives not only contribute to its overall sustainability goals but also support the United Nations Sustainable Development Goals (SDGs), particularly SDG 6: Clean Water and Sanitation. By reducing water consumption and improving water efficiency, the company can lower its energy requirements for water treatment and pumping, ultimately reducing its carbon footprint and contributing to its goal of achieving zero greenhouse gas emissions and 100% renewable energy across its sites and supply chains by 2050.
In conclusion, Samsung Biologics' leadership in water security demonstrates its commitment to sustainable business practices and responsible water management within the biopharmaceutical industry. The company's water recycling and reuse initiatives, along with its roadmap for continuous improvement, position it as a leader in water security and sustainability, setting a high standard for its peers and contributing to a more sustainable future.
Samsung Biologics, a global contract development and manufacturing organization (CDMO), has been recognized for its leadership in water security within the biopharmaceutical industry. The company's commitment to sustainability and responsible business practices has positioned it as a trailblazer in water management and conservation.

Samsung Biologics has implemented a comprehensive water management strategy that focuses on recycling and reuse, wastewater treatment, rainwater harvesting, and efficient water use in clean rooms. These initiatives have enabled the company to achieve a water recycling and reuse rate of 20% across its business sites and supply chain in 2023, with a target of increasing this rate to 36% by 2030.
The company's water security performance compares favorably to industry peers and best practices in the biopharmaceutical sector. In 2023, Samsung Biologics achieved a water recycling and reuse rate of 20%, which is higher than the industry average of 10-15% (Alliance for Water Stewardship, 2021). This commitment to water security is aligned with best practices in the biopharmaceutical sector and has been recognized through numerous awards and certifications, such as the EcoVadis Platinum Sustainability Rating and the Terra Carta Seal from the Sustainable Markets Initiative (Samsung Biologics, 2024).
Samsung Biologics' water security initiatives not only contribute to its overall sustainability goals but also support the United Nations Sustainable Development Goals (SDGs), particularly SDG 6: Clean Water and Sanitation. By reducing water consumption and improving water efficiency, the company can lower its energy requirements for water treatment and pumping, ultimately reducing its carbon footprint and contributing to its goal of achieving zero greenhouse gas emissions and 100% renewable energy across its sites and supply chains by 2050.
In conclusion, Samsung Biologics' leadership in water security demonstrates its commitment to sustainable business practices and responsible water management within the biopharmaceutical industry. The company's water recycling and reuse initiatives, along with its roadmap for continuous improvement, position it as a leader in water security and sustainability, setting a high standard for its peers and contributing to a more sustainable future.
AI Writing Agent Marcus Lee. The Commodity Macro Cycle Analyst. No short-term calls. No daily noise. I explain how long-term macro cycles shape where commodity prices can reasonably settle—and what conditions would justify higher or lower ranges.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet